⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11037673 | 1.00 | THRB (0.50) | — | |
| SCHEMBL4339778 | 1.00 | THRB (0.50) | — | |
| SCHEMBL4343364 | 1.00 | — | — | |
| SCHEMBL2355497 | 0.97 | — | — | |
| SCHEMBL14879481 | 0.85 | LPAR2 (0.53) | — | |
| SCHEMBL23120561 | 0.78 | THRB (0.67) | — | |
| SCHEMBL19839915 | 0.78 | THRB (0.67) | — | |
| Heptane SCHEMBL5048015 | 0.75 | — | — | |
| Octane SCHEMBL455294 | 0.75 | — | — | |
| SCHEMBL21044729 | 0.73 | THRB (0.70) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6380197-B1 | FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES | AVENTIS PHARMA S. A. (FR) | 2002-04-30 | — | — | US | claimed |
| EP-1001943-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | Aventis Pharma S.A. (FR) | 2000-05-24 | — | — | EP | claimed |
| WO-1999003843-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1999-01-28 | — | — | WO | claimed |
| CN-112074983-A | Electrolyte for lithium ion secondary battery and lithium ion secondary battery | 株式会社村田制作所 | 2020-12-11 | — | — | CN | disclosed |
| EP-2022793-A1 | NOVEL HETEROCYCLIC COMPOUND OR SALT THEREOF AND INTERMEDIATE THEREOF | TOYAMA CHEMICAL CO., LTD. (JP) | 2009-02-11 | — | — | EP | disclosed |
| US-6380197-B1 | FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES | AVENTIS PHARMA S. A. (FR) | 2002-04-30 | — | — | US | disclosed |
| EP-1001943-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | Aventis Pharma S.A. (FR) | 2000-05-24 | — | — | EP | disclosed |
| WO-1999003843-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1999-01-28 | — | — | WO | disclosed |
| EP-0668259-A1 | A method for the preparation of optically active 2-aryl alkyl aldehydes and formation of 2-aryl-alkanoic acids therefrom | MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG (DE) | 1995-08-23 | — | — | EP | disclosed |
| US-5434302-A | Method for the preparation of optically active 2-aryl alkyl aldehydes and formation of 2-aryl-alkanoic acids therefrom | PARADIES H HENRICH (DE) | 1995-07-18 | — | — | US | disclosed |
| EP-0263911-B1 | LOW-FOAM ALKALI-STABLE AMPHOTERIC SURFACE ACTIVE AGENTS | RHONE-POULENC INC. (US) | 1991-08-21 | — | — | EP | disclosed |
| US-4978781-A | CLEANING COMPOUNDS | MIRANOL, INC. (US) | 1990-12-18 | — | — | US | disclosed |
| US-4891159-A | HYDROXYPROPYLSULTAINES | MIRANOL INC. (US) | 1990-01-02 | — | — | US | disclosed |
| EP-0263911-A1 | Low-foam alkali-stable amphoteric surface active agents | RHONE-POULENC INC. (US) | 1988-04-20 | — | — | EP | disclosed |